|
|||||
BSE shares have jumped 15% in the past month and now sit just 6% below their record high of Rs 3,030. The stock has rebounded nearly 50% from its late-September low as concerns over possible F&O curbs eased. After sliding sharply due to regulatory uncertainty, the exchange has staged a strong comeback, drawing renewed investor attention.
Category:
News and Media
Indian pharmaceutical stocks, including Lupin, Shilpa Medicare, and Natco Pharma, are under scrutiny following recent USFDA inspections at their manufacturing sites. These audits yielded regulatory observations, prompting companies to address the findings. Alkem Laboratories, however, reported no critical issues from a separate Armenian health ministry audit at its Sikkim facility.
Category:
News and Media
Experts criticised overly complex rules and called for an overhaul of Britain's nuclear strategy.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||